About Vkt Pharma Private Limited
Data last updated: 24 December 2025
Vkt Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 31 May 2006, the company has been in operation for over 20 years.
Registered with ROC Hyderabad under CIN U24100AP2006PTC050221.
Capital: an authorised share capital of ₹12 Cr and a paid-up capital of ₹11.06 Cr. Formerly known as Potluri Builders Private Limited. It is led by directors including Vamsi Krishna Potluri and Ramesh Babu Potluri.
Last AGM: 29 September 2025. Financial statements filed for year ended 31 March 2025. Office: Hyderabad, Telangana.
The company has a workforce of approximately 238 employees as per the latest available data.
The company is associated with 1 brand - Vkt Pharma. As per MCA filings, the company has open charges of ₹340 Cr and satisfied charges of ₹355.79 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vktpharma.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressPlot No. 72 H.No: 8 – 2 – 334/3&4 Road No. 5 Opp. Sbi Executive Enclave Banjara Hill, S, Hyderabad, Telangana, India – 500034
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Vkt Pharma Private Limited
Vkt Pharma Private Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG2006PTC050221, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2006PTC050221 | Current |
| U24100AP2006PTC050221 | Previous |
| U45201AP2006PTC050221 | Previous |
Associated Brands with Vkt Pharma Private Limited
Vkt Pharma Private Limited operates one associated brand: VKT Pharma. These brands represent Vkt Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures generic pharmaceutical products with R&D and global partnerships. | vktpharma.com |
Competitors & Alternatives of Vkt Pharma Private Limited
Brands and companies operating in the same space as Vkt Pharma Private Limited include Inventia Healthcare, Zim Labs, Lotus and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Inventia Healthcare
|
Oral solid drug delivery systems are manufactured and developed. | Mumbai, India, India | 1985 |
Zim Labs
|
Solid and semisolid dosage forms are developed and manufactured. | Nagpur, India, India | 1989 |
Lotus
|
Contract manufacturing for oral solid formulations is offered. | Taipei, Taiwan, Taiwan | 1966 |
Contract Pharmacal Corp.
|
Product development, manufacturing and packaging services | Hauppauge, United States, United States | 1971 |
Adare Pharma Solutions
|
CDMO manufacturing solid drugs | Lawrence Township, United States, United States | 2015 |
Suzhou Ze Jing Biological Pharmaceutical
|
Company developing small molecules & eukaryotic cell based recombinant protein drugs | Suzhou, China, China | 2009 |
Halewood Laboratories
|
Provides contract manufacturing services for food, pharmaceuticals, and related products globally. | Ahmedabad, India, India | 1984 |
Capsugel
|
Dosage forms are delivered for preclinical, clinical, and commercial supply. | Morristown, United States, United States | 1875 |
Glukem
|
Manufactures pellets, micro-pellets, granules, and capsules for pharmaceutical and nutraceutical drugs. | Hyderabad, India, India | 2014 |
Vovantis Laboratories
|
Develops and manufactures novel effervescent drug delivery systems. | Vadodara, India, India | 2008 |
Business Activity of Vkt Pharma Private Limited
Vkt Pharma Private Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Manufacturing | ********* | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Board of Directors of Vkt Pharma Private Limited
Vkt Pharma Private Limited is currently managed by 5 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Vamsi Krishna Potluri
Also directs:
Sms Pharmaceuticals Limited, Sms Peptides Private Limited, Potluri Infra Projects Llp and 3 more
|
Managing Director | 16 Aug 2014 | 11 Years 10 Months | Current |
|
Ramesh Babu Potluri
Also directs:
Potluri Agri Farms Llp, Sms Pharmaceuticals Limited, Sms Peptides Private Limited and 1 more
|
Director | 31 May 2006 | 20 Years 1 Months | Current |
|
Hima Bindu Potluri
Also directs:
Potluri Agri Farms Llp
|
Director | 31 May 2006 | 20 Years 1 Months | Current |
Financials of Vkt Pharma Private Limited FY 2025 filings available
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings of Vkt Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Nov 2025 | Others | ₹20 Cr | Open |
| 20 Nov 2025 | Others | ₹150 Cr | Open |
| 13 Oct 2025 | Others | ₹150 Cr | Open |
| 26 Sep 2024 | Others | ₹20 Cr | Open |
| 02 Nov 2023 | Others | ₹130 Cr | Satisfied |
Total charge records: 10 View all charges
Employees and EPFO Compliance at Vkt Pharma Private Limited
View historical data on people associated with Vkt Pharma Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Vkt Pharma Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Vkt Pharma Private Limited
GSTIN & GST Filing Data of Vkt Pharma Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Vkt Pharma Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Vkt Pharma Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Vkt Pharma Private Limited
MSME Payment Delays by Vkt Pharma Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Vkt Pharma Private Limited
Subsidiaries & Group Companies of Vkt Pharma Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Vkt Pharma Private Limited with ownership details.
MCA Filings & Documents of Vkt Pharma Private Limited
MCA Filings & Documents of Vkt Pharma Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Vkt Pharma Private Limited
Frequently Asked Questions about Vkt Pharma Private Limited
Vkt Pharma Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 31 May 2006 (20+ years old) and is registered under CIN U24100TG2006PTC050221. The company has 238 employees.
The current directors of Vkt Pharma Private Limited are:
- Vamsi Krishna Potluri
- Shivangi Jain
- Ramesh Babu Potluri
- Hima Bindu Potluri
- Kriti Baid
The primary industry of Vkt Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Vkt Pharma Private Limited can be reached at the registered office: Plot No. 72 H.No: 8 – 2 – 3343&4 Road No. 5 Opp. Sbi Executive Enclave Banjara Hill, S, Hyderabad, Telangana, India – 500034, or through the website vktpharma.com.
The authorised capital is ₹12 Cr, and the paid-up capital is ₹11.06 Cr.
The company has its registered office at Plot No. 72 H.No: 8 – 2 – 3343&4 Road No. 5 Opp. Sbi Executive Enclave Banjara Hill, S, Hyderabad, Telangana, India – 500034.